---
title: "R for Bio Data Science"
subtitle: "TCGA Pan-Cancer Analysis with Emphasis on Survival Analysis"
# author: "Jasmin Gade Støvlbæk, Monica Nielsen, Sina Ahmadzai, Yusuf Tunc"
format:
  revealjs:
    embed-resources: true
editor: visual
---

## Introduction to TCGA Pan-Cancer Dataset 
::: {style="font-size: 50%;"}
::: fragment
-   The Cancer Genome Atlas (TCGA)
:::
:::

::: {style="font-size: 50%;"}
::: fragment
-   Establishing coordinated effort to characterize molecular events in primary cancers
:::
:::

::: {style="font-size: 50%;"}
::: fragment
-   Collection of clinicopathologic annotation data along with multi-platform molecular profiles of more than 11,000 human tumors across 34 different cancer type
:::
:::

::: {style="font-size: 50%;"}
::: fragment
-   Our data is composed of the 6 cancer types with most patients included
:::
:::

::: {style="font-size: 50%;"}
::: fragment
-   Significance of the Pan-Cancer dataset in cancer genomics research
     - Pan-cancer dataset allows for simultaneous analysis of genomic data across a diverse range of cancer types
:::
:::

::: {style="font-size: 50%;"}
::: fragment
-   Dataset is crucial for discovering shared molecular features, potential biomarkers and theurapeutic targets
:::
:::

::: {style="font-size: 50%;"}
::: fragment
-   Contributing to more effective and personalized cancer treatments
:::
:::

::: {style="font-size: 50%;"}
::: fragment
-   How this dataset helps in understanding cancer at a molecular level
:::
:::

::: {style="font-size: 50%;"}
::: fragment
-  Data includes patient bar code, type of cancer, age at diagnosis, and pathologic tumor stage
:::
:::

::: {style="font-size: 50%;"}
::: fragment
-   This dataset facilitates a nuanced understanding of molecular intricacies of cancer
:::
:::

::: {style="font-size: 50%;"}
::: fragment
-   Data set helps allowing identification of patterns and shared characteristics among different cancer types\
:::
:::

## Project Aim and Focus

-   To perform an in-depth TCGA Pan-Cancer analysis, focusing on survival analysis

::: {style="font-size: 50%;"}
::: fragment
-   Explore and understand factors influencing survival outcomes within the TCGA dataset
:::
:::

::: {style="font-size: 50%;"}
::: fragment 
- Performing Cox Proportional Hazard Models 
:::
:::

## Data Acquisition and Cleaning
::: {style="font-size: 50%;"}
::: fragment
-   Data retrieved and loaded using read_excel()
:::
:::

::: {style="font-size: 50%;"}
::: fragment
-   Raw data is a 11.160 x 34 sized tibble:
:::
:::

::: {style="font-size: 30%;"}
::: fragment
```{r}
#| label: load data to tibble
#| message: false
#| warning: false


library(tidyverse)
TCGA <- read_tsv("./../data/01_dat_load.tsv")

TCGA |> 
  slice_head(n=3) |> 
  knitr::kable()

```
:::
:::

::: {style="font-size: 50%;"}
::: fragment
-   Initial data exploration: 
    -   E.g. using slice_head, glimpse and names
    -   Identify NAs
:::
:::

::: {style="font-size: 50%;"}
::: fragment
-   Cleaning: 
    -   Remove index
    -   Assign non-NA missing information to factors
    -   Drop columns with >80% missing values
    -   Impute remaining NAs: Numeric values to median and categorical values to most frequently occuring string
    -   Rename columns for clarification
:::
:::


## Data Transformation and Tools

::: {style="font-size: 50%;"}
::: fragment
-   Mutate two new columns, by calculating: 
    -   "age_at_last_followup_years"
    -   "disease_duration_years" 
:::
:::

::: {style="font-size: 50%;"}
::: fragment
-   Mutate a new column "age_group_diagnosis" where patients are divided into age categories
:::
:::

::: {style="font-size: 50%;"}
::: fragment
-   Define function to assign new variable "stage_group" based om: 
    -   "clinical_stage"
    -   "pathological_stage" 
:::
:::

::: {style="font-size: 50%;"}
::: fragment
-   Create subset of the data from the top 6 cancer types:
:::
:::


::: {style="font-size: 50%;"}
::: fragment
```{r}
#| label: show subsetting
#| eval: false
#| echo: true


top_cancer_types <- TCGA_clean |> 
  count(cancer_type) |> 
  arrange(desc(n)) |> 
  slice(1:6) |> 
  pull(cancer_type)

TCGA_aug <- TCGA_aug |> 
  filter(cancer_type %in% top_cancer_types)
```
:::
:::

::: {style="font-size: 50%;"}
::: fragment
-   ... Leaving us with a new tibble TCGA_aug sized 3.893 x 33 ready for description and analysis
:::
:::

## Exploratory Data Analysis Insights

-   Summarize key findings from the EDA.

-   Include visualizations like bar charts or scatter plots to illustrate cancer-specific patterns.

## Survival Analysis Outcomes
::: {style="font-size: 50%;"}
::: columns
::: {.column width="35%"}
-  Main results from the CoxPH model

::: {style="font-size: 50%;"}
:::fragment 
- We fitted a CoxPH model to examine impact of various predictors 
:::
:::

::: {style="font-size: 50%;"}
:::fragment 
- Our predictors include, cancer type, age at diagnosis, gender and race on survival
:::
:::

::: {style="font-size: 50%;"}
:::fragment 
- We also performed strata, which is the function used to account for different cancer types 
:::
:::

::: {.column width="62%"}
![Survival Plot](./../results/05_analysis_1/05_survival_plot.png)
:::


## Interpreting the Model

::: {style="font-size: 50%;"}
::: columns
::: {.column width="35%"}
-   Direct comparison of HR across cancer types without stratification
    -   Understanding relative risks associated with each factor

::: fragment
-   GMB stands out - Risk of death nine times greater
:::

::: fragment
-   Age - Risk of death increases slightly with each additional year
:::

::: fragment
-   Gender - No significant difference based on gender
:::

::: fragment
-   Cancer stage - Stage 4 risk of death six times greater
:::
:::

::: {.column width="3%"}
:::

::: {.column width="62%"}
![Proportional Hazard Ratio Plot](./../results/05_analysis_1/05_hazardR_plot.png){fig-align="right"}
:::
:::
:::

## Implications and Limitations

-   Significance for Oncology

::: fragment
```         
-   Cox model identifies survival-related factors
```
:::

::: fragment
```         
-   Guides prognosis and treatment strategies
```
:::

::: fragment
```         
-   Stresses need for early detection and robust treatments
```
:::

::: fragment
-   Study Limitations
:::

::: fragment
```         
-   Model may omit key influencing factors (lifestyle, socioeconomics)
```
:::

::: fragment
```         
-   Potential unaccounted variable interactions
```
:::

## Conclusion and Future Outlook

::: {style="font-size: 50%;"}
::: columns
::: {.column width="35%"}
-   Significance for Oncology

::: fragment
```         
  - Employed TCGA Pan-Cancer dataset for survival factor analysis
  - Identified age and cancer type as critical survival predictors
```
:::

::: fragment
-   Contribution to Precision Medicine
:::

::: fragment
```         
  - Aligns with personalized care based on patient-specific data
  - Promises enhanced predictive accuracy with more genomic information
```
:::

::: fragment
-   Future Research Trajectory
:::

::: fragment
```         
  - Aims for advanced models to deepen cancer survival understanding
  - Sets a foundation for improved patient treatment and survival rates
```
:::
:::

::: {.column width="3%"}
:::

::: {.column width="62%"}
![Survival Plot](./../results/05_analysis_1/05_survival_plot.png)
:::
:::
:::
